Repligen Z Score

RGEN
 Stock
  

USD 237.75  3.46  1.43%   

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Additionally, take a look at Repligen Piotroski F Score and Repligen Valuation analysis.
  
Repligen Invested Capital Average is quite stable at the moment as compared to the past year. The company's current value of Invested Capital Average is estimated at 117.6 Million. Market Capitalization is expected to rise to about 1 B this year, although the value of Capital Expenditure will most likely fall to (5.1 M). Repligen Interest Expense is quite stable at the moment as compared to the past year. The company's current value of Interest Expense is estimated at 3.66 Million. Net Income is expected to rise to about 138.4 M this year, although the value of Weighted Average Shares will most likely fall to about 44.9 M.

Repligen Z Score Analysis

Repligen's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2015 2016 2021 2022 (projected)
Enterprise Value883.44 M978.92 M881.02 M950.58 M
Average Equity118.59 M156.97 M141.28 M152.43 M
Z Score 
 = 
Sum Of  
 
5 Factors 
More About Z Score | All Equity Analysis

Current Repligen Z Score

    
  28.1  
Most of Repligen's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repligen Cp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
 = 
1.2 * (
Working Capital
/
Total Assets )
Second Factor
 = 
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
 = 
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
 = 
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
 = 
0.99 * (
Revenue
/
Total Assets )

Repligen Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Repligen is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Repligen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Repligen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Repligen's interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

Based on the company's disclosures, Repligen Cp has a Z Score of 28.1. This is 316.3% higher than that of the Healthcare sector and notably higher than that of the Medical Instruments & Supplies industry. The z score for all United States stocks is notably lower than that of the firm.

Repligen Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repligen's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Repligen could also be used in its relative valuation, which is a method of valuing Repligen by comparing valuation metrics of similar companies.
Repligen is currently under evaluation in z score category among related companies.

Repligen Current Valuation Drivers

We derive many important indicators used in calculating different scores of Repligen from analyzing Repligen's financial statements. These drivers represent accounts that assess Repligen's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Repligen's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee59.56 K30.32 K28.14 K54.33 K415.18 K447.96 K
Revenue Per Employee296.71 K354.07 K355.12 K332.05 K2.17 M2.34 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA24.2 M43.92 M56.31 M109.39 M216.23 M233.31 M

Repligen Fundamentals

About Repligen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Repligen Cp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repligen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repligen Cp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts. Repligen operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1852 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Repligen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Currently Active Assets on Macroaxis

Additionally, take a look at Repligen Piotroski F Score and Repligen Valuation analysis. Note that the Repligen Cp information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Repligen Stock analysis

When running Repligen Cp price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.38
Market Capitalization
13.4 B
Quarterly Revenue Growth YOY
0.27
Return On Assets
0.0591
Return On Equity
0.0936
The market value of Repligen Cp is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine Repligen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.